- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.12.25 | Its future still in limbo, CSL Seqirus debuts $1B flu shot, antivenom plant in Australia | ||
| 08.12.25 | Meds from Pfizer, Lilly, J&J and more secure spots in China's 1st private insurance formulary | ||
| 08.12.25 | Fast-rising UCB set to file for Fintepla approval in 3rd epileptic disorder after trial win | ||
| 08.12.25 | Amgen inks LA sports, entertainment partnership, setting up 2026 World Cup presence | ||
| 05.12.25 | Lowering FDA fees would spur generics manufacturing in US, Mark Cuban says | ||
| 05.12.25 | CDC's ACIP votes to change long-standing hepatitis B vaccine guidance for newborns, prompting backlash | ||
| 05.12.25 | AbbVie revs up Skyrizi spending to top TV ad totals in November, edging out J&J's Tremfya | ||
| 05.12.25 | The biopharma dealmaking landscape and what to expect in 2026 | ||
| 05.12.25 | BMS scores 5th indication for Breyanzi with FDA marginal zone lymphoma nod | ||
| 05.12.25 | Avalere Health hires Sarah Hall to lead US marketing team through 'politically dynamic' period | ||
| 05.12.25 | Merck's Keytruda SC launch in Germany faces new hurdle as Halozyme scores preliminary injunction | ||
| 05.12.25 | Fierce Pharma Asia-FDA safety probe of Takeda drug; Otsuka kidney disease nod; ADC patent fight | ||
| 04.12.25 | CDC's ACIP pushes back planned vote on newborn hepatitis B vaccines as confusion, debate abound | ||
| 04.12.25 | Pfizer, GSK, Shionogi sponsor London run of musical about antimicrobial resistance | ||
| 04.12.25 | Daiichi Sankyo receives FDA untitled letter taking aim at Turalio patient ambassador video | ||
| 04.12.25 | FDA leadership churn continues with transfer of OTC drug office director | ||
| 04.12.25 | A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes | ||
| 04.12.25 | Quvara Medical debuts as latest CDMO after Buckland Group buys Becton Dickinson facility | ||
| 04.12.25 | After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg | ||
| 03.12.25 | Cosmo shares zoom with results from 2 male-pattern hair loss trials | ||
| 03.12.25 | Daiichi Sankyo prevails on appeal in long-running ADC patent battle with Seagen, flipping prior $41.8M verdict | ||
| 03.12.25 | Johnson & Johnson directs a new campaign for aging eyes with Naomi Watts in the spotlight | ||
| 03.12.25 | With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis | ||
| 03.12.25 | Excelsior collects $95M on mission to accelerate discovery, production of small molecules | ||
| 03.12.25 | Workplaces labor to keep staff as fertility support falls short, Ferring survey finds |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .